Literature DB >> 25578260

Macrophage activation and its role in repair and pathology after spinal cord injury.

John C Gensel1, Bei Zhang2.   

Abstract

The injured spinal cord does not heal properly. In contrast, tissue repair and functional recovery occur after skin or muscle injuries. The reason for this dichotomy in wound repair is unclear but inflammation, and specifically macrophage activation, likely plays a key role. Macrophages have the ability to promote the repair of injured tissue by regulating transitions through different phase of the healing response. In the current review we compare and contrast the healing and inflammatory responses between spinal cord injuries and tissues that undergo complete wound resolution. Through this comparison, we identify key macrophage phenotypes that are inaptly triggered or absent after spinal cord injury and discuss spinal cord stimuli that contribute to this maladaptive response. Sequential activation of classic, pro-inflammatory, M1 macrophages and alternatively activated, M2a, M2b, and M2c macrophages occurs during normal healing and facilitates transitions through the inflammatory, proliferative, and remodeling phases of repair. In contrast, in the injured spinal cord, pro-inflammatory macrophages potentiate a prolonged inflammatory phase and remodeling is not properly initiated. The desynchronized macrophage activation after spinal cord injury is reminiscent of the inflammation present in chronic, non-healing wounds. By refining the role macrophages play in spinal cord injury repair we bring to light important areas for future neuroinflammation and neurotrauma research. This article is part of a Special Issue entitled SI: Spinal cord injury.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative activation; Arginase; Astrocyte; Axon; CD206; Dieback; ECM; Fizz-1; Healing; IL-10; IL-12; IL-1b; IL-4; IL-6; Immune complex; Inflammation; LPS; M1; M2; M2b; M2c; MARCO; Macrophage; Mannose; Microglia; Monocyte; Myelination; Neuroinflammation; Neurotrauma; OPC; Oligodendrocyte; PPAR; Phenotype; Proliferation; Reactive oxygen species; Receptor; Regeneration; Regulatory; Remyelination; Retraction; SCI; SLAM; STAT3; STAT6; TBI; TGF-beta; TLR; TNF-alpha; Transcription factors; Traumatic brain injury; VEGF; Wound; Ym1

Mesh:

Year:  2015        PMID: 25578260     DOI: 10.1016/j.brainres.2014.12.045

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  225 in total

1.  Repair, protection and regeneration of spinal cord injury.

Authors: 
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

2.  Sophorolipid Butyl Ester Diacetate Does Not Affect Macrophage Polarization but Enhances Astrocytic Glial Fibrillary Acidic Protein Expression at Micromolar Concentrations in Vitro.

Authors:  Alexis M Ziemba; Manoj K Gottipati; Filbert Totsingan; Cheryl M Hanes; Richard A Gross; Michelle R Lennartz; Ryan J Gilbert
Journal:  ACS Chem Neurosci       Date:  2017-02-07       Impact factor: 4.418

3.  Inhibition of NOX2 signaling limits pain-related behavior and improves motor function in male mice after spinal cord injury: Participation of IL-10/miR-155 pathways.

Authors:  Boris Sabirzhanov; Yun Li; Marino Coll-Miro; Jessica J Matyas; Junyun He; Alok Kumar; Nicole Ward; Jingwen Yu; Alan I Faden; Junfang Wu
Journal:  Brain Behav Immun       Date:  2019-02-23       Impact factor: 7.217

4.  Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: introduction of an alternative therapy.

Authors:  Khashayar Afshari; Amir Dehdashtian; Nazgol-Sadat Haddadi; Arvin Haj-Mirzaian; Arad Iranmehr; Mohammad Ali Ebrahimi; Seyed Mohammad Tavangar; Hedyeh Faghir-Ghanesefat; Fatemeh Mohammadi; Nastaran Rahimi; Abbas Norouzi Javidan; Ahmad Reza Dehpour
Journal:  Spinal Cord       Date:  2018-06-29       Impact factor: 2.772

Review 5.  Platelet "first responders" in wound response, cancer, and metastasis.

Authors:  David G Menter; Scott Kopetz; Ernest Hawk; Anil K Sood; Jonathan M Loree; Paolo Gresele; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

Review 6.  Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury.

Authors:  Timothy J Kopper; John C Gensel
Journal:  J Neurosci Res       Date:  2017-07-11       Impact factor: 4.164

Review 7.  Microglia and macrophage metabolism in CNS injury and disease: The role of immunometabolism in neurodegeneration and neurotrauma.

Authors:  Nicholas A Devanney; Andrew N Stewart; John C Gensel
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

Review 8.  Mesenchymal Stem Cell-Macrophage Choreography Supporting Spinal Cord Repair.

Authors:  Inés Maldonado-Lasunción; Joost Verhaagen; Martin Oudega
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 9.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

10.  Disrupting protein tyrosine phosphatase σ does not prevent sympathetic axonal dieback following myocardial infarction.

Authors:  Dustin Johnsen; Antoinette Olivas; Bradley Lang; Jerry Silver; Beth Habecker
Journal:  Exp Neurol       Date:  2015-11-23       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.